Alastair J M Watson Selected Research

Alastair J M Watson Research Topics

Disease

6	Neoplasms (Cancer) 11/2019 - 11/2004
4	Crohn Disease (Crohn's Disease) 01/2022 - 04/2007
4	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 02/2006
3	Inflammation (Inflammations) 01/2019 - 10/2015
3	Adenoma (Adenomas) 08/2007 - 05/2003
2	Colonic Neoplasms (Colon Cancer) 11/2019 - 02/2012
2	Necrosis 10/2015 - 04/2007
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2012 - 01/2011
2	Ulcerative Colitis 02/2011 - 01/2011
1	Dysbiosis 11/2019
1	Rectal Neoplasms (Rectal Cancer) 11/2019
1	Atrophy 01/2019
1	Fibrosis (Cirrhosis) 12/2013
1	Body Weight (Weight, Body) 11/2013
1	Carcinogenesis 10/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2007
1	Herpes Zoster 10/2006
1	Herpes Simplex 11/2004
1	Carcinoma (Carcinomatosis) 11/2004

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 02/2016 - 11/2004
2	Proteins (Proteins, Gene)FDA Link 10/2013 - 02/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2011 - 09/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Amoxicillin (Wymox)FDA LinkGeneric 11/2019
1	TetracyclinesIBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2019
1	Penicillins (Penicillin)FDA Link 11/2019
1	Ampicillin (Omnipen)FDA LinkGeneric 11/2019
1	geranylgeranyltransferase type-I (protein geranylgeranyltransferase)IBA 02/2016
1	ClaudinsIBA 10/2015
1	InterferonsIBA 10/2015
1	InterleukinsIBA 10/2015
1	Interleukin-6 (Interleukin 6)IBA 12/2013
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2012
1	PoisonsIBA 02/2012
1	Infliximab (Remicade)FDA Link 02/2011
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2011
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	Vitamin K 3 (Menadione)FDA Link 07/2009
1	trichostatin A (A 300)IBA 09/2007
1	Dinoprostone (PGE2)FDA Link 09/2007
1	ChemokinesIBA 09/2007
1	rofecoxib (Vioxx)FDA Link 09/2007
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2007
1	ProstaglandinsIBA 09/2007
1	AntibodiesIBA 10/2006
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 10/2006
1	Butyrates (Butyrate)IBA 02/2006
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2006
1	Ganciclovir (Cytovene)FDA LinkGeneric 11/2004
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2004
1	flt3 ligand protein (flt3 ligand)IBA 11/2004
1	ProdrugsIBA 11/2004
1	Thymidine KinaseIBA 11/2004
1	GastrinsIBA 05/2003
1	CarcinogensIBA 05/2003
1	big gastrinIBA 05/2003

Therapy/Procedure

2	Lasers (Laser) 07/2012 - 01/2011
1	Transjugular Intrahepatic Portasystemic Shunt 01/2019
1	Aftercare (After-Treatment) 11/2013
1	Biological Therapy 10/2013
1	Colonoscopes 08/2007
1	Therapeutics 04/2007
1	Chemoprevention 02/2006